OPRX

OPTIMIZERX CORP

OPRX·68401U204·US·Common Stock·Healthcare - Health Information Services-Activist

OPRX (OPTIMIZERX CORP) is held by 70 institutional investors as of Q2 2026. Largest holders: ROYCE & ASSOCIATES LP ($6.2M), VANGUARD CAPITAL MANAGEMENT LLC ($4M), BLAIR WILLIAM & CO/IL ($3.5M). Net institutional sentiment: Mixed.

70
Holders
(6 Elite)
$39M
Total Value
39% (84)
Consensus
33 buying - 51 selling
13F: Insider & Congress: Updated regularly
OPRX

Smart Money Verdict

View all
Loading verdict
Held by 70 funds
6 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Aug 24, 2026 · Activists Aug 14, 2026 · Congress none

InsiderDJD'Silva Andrew J.Tax 1K shAug 21, 2026
InsiderMWMerrell Brendan W.Tax 1K shAug 21, 2026
InsiderOMOdence-Ford MarionTax 2K shAug 21, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.1M(+22.7%)$6.2M0.1%+34.13%
33
Increased
699,604(+2.1%)$4M0.0%+6.35%
27
Decreased
607,925(-1.1%)$3.5M0.0%-44.15%
0
Increased
583,956(+171.7%)$3.3M0.0%+17.33%
43
Decreased
477,687(-15.2%)$2.7M0.0%-31.22%
0
Decreased
445,382(-61.7%)$2.5M0.0%+45.65%
0
Decreased
207,345(-47.1%)$1.2M0.0%-63.79%
0
Decreased
169,538(-48.8%)$969,7570.0%+5.87%
0
Decreased
167,700(-22.7%)$959,2440.0%-8.22%
0
Increased
162,186(+418.4%)$927,7040.0%+29.81%
40
New
157,992$903,7150.0%+35.49%
34
Increased
156,314(+104.7%)$894,1160.0%+4.29%
27
Decreased
138,084(-3.4%)$789,8400.0%-32.92%
0
New
122,086$698,3320.0%+35.49%
34
Decreased
105,037(-70.7%)$600,8120.0%-22.95%
0
Increased
99,124(+102.2%)$566,9890.0%+9.01%
39
Decreased
97,999(-11.8%)$560,5540.0%+5.87%
0
Decreased
89,666(-34.5%)$512,8900.0%+5.87%
0
Unchanged
89,200$510,2240.0%-37.45%
0
Decreased
80,602(-83.1%)$461,0430.0%-43.02%
0

Showing 1-20 of 90

1 / 5
OPRXOPRXOPTIMIZERX CORP

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used